M11.152 Familial chondrocalcinosis, left hip

Name of the Condition

• Familial chondrocalcinosis, left hip

Summary

Familial chondrocalcinosis, left hip is a hereditary condition characterized by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals in the left hip joint and surrounding tissues. This leads to inflammation, pain, and potential joint damage. It is part of the broader group of crystal arthropathies and is distinguished by its familial inheritance pattern and left hip-specific involvement. Diagnosis typically involves clinical evaluation, imaging, and sometimes crystal identification in joint fluid or tissue.

Causes

Familial chondrocalcinosis, left hip is caused by genetic mutations that influence calcium pyrophosphate crystal formation in the left hip’s cartilage, synovium, or periarticular structures. These mutations may affect enzymes or proteins involved in crystal metabolism, leading to abnormal crystal deposition. The condition is inherited, though the exact genetic pathways vary.

Risk Factors

• Family history of chondrocalcinosis or related crystal arthropathies.
• Advanced age (increases likelihood of crystal deposition).
• Metabolic conditions affecting calcium or phosphate levels.
• Hip trauma or surgery (may trigger crystal release).
• Chronic inflammatory joint diseases.

Symptoms

• Left hip pain, swelling, and stiffness.
• Recurrent episodes of acute inflammation.
• Reduced range of motion in the left hip.

Diagnosis

Diagnosis of familial chondrocalcinosis, left hip involves a combination of clinical evaluation, imaging studies (e.g., X-rays, ultrasound, or MRI), and sometimes analysis of joint fluid or tissue to identify CPPD crystals. Clinical assessment focuses on symptoms and family history, while imaging may reveal characteristic crystal deposits or joint changes. Crystal identification in synovial fluid confirms the diagnosis.

Treatment Options

Treatment aims to manage symptoms and reduce inflammation. Options include nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and swelling, corticosteroid injections for severe inflammation, and colchicine for acute flare-ups. Physical therapy may help maintain joint function. In advanced cases, surgical intervention (e.g., joint repair or replacement) may be considered.

Prognosis and Follow-Up

Prognosis varies based on the extent of joint damage and response to treatment. Early diagnosis and management can help control symptoms and slow progression. Regular follow-up with a healthcare provider is recommended to monitor joint function, adjust treatment, and address complications. Long-term outcomes depend on the severity of crystal deposition and adherence to therapy.

Complications

Potential complications include chronic joint pain, reduced mobility, and progressive joint damage leading to osteoarthritis. Recurrent acute flare-ups may occur, and in severe cases, joint deformity or disability may develop. Prompt treatment can mitigate these risks.

Lifestyle & Prevention

Lifestyle modifications may help manage symptoms, such as maintaining a healthy weight to reduce hip stress, engaging in low-impact exercise to preserve mobility, and avoiding activities that exacerbate pain. While genetic factors cannot be prevented, managing underlying metabolic conditions (e.g., calcium or phosphate imbalances) may reduce crystal deposition risk.

When to Seek Professional Help

Seek medical attention if you experience persistent left hip pain, swelling, or stiffness, especially with reduced range of motion. Acute, severe symptoms (e.g., sudden intense pain, inability to bear weight) warrant immediate evaluation to rule out complications like joint infection or severe inflammation.

Tips for Medical Coders

Document the left hip involvement and familial nature of the condition clearly in the medical record. Ensure the diagnosis aligns with clinical findings, imaging, or crystal identification. Verify that the code M11.152 is used when the condition is specifically localized to the left hip and has a familial basis, as opposed to unilateral or non-familial presentations.